Lemoine H, Ehle B, Kaumann A J
Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):40-51. doi: 10.1007/BF00498850.
A radioligand that selectively labels beta 2-adrenoceptors, 3H-ICI 118,551 (3H-ICI), is introduced. Experiments were performed on guinea-pig tissues. The binding characteristics of 3H-ICI on lung membrane particles are compared with the blocking characteristics of ICI 118,551 against the tracheo-relaxant effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol. Binding to both beta 1- and beta 2-adrenoceptors were also performed with 3H-(-)-bupranolol on lung and ventricular myocardium. The binding inhibition characteristics of unlabelled ICI 118,551 on ventricle were compared with its characteristics as antagonist of the positive chronotropic effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol in spontaneously beating right atria. 1. ICI 118,551 blocked more the relaxant effects of (+/-)-fenoterol and (-)-adrenaline than those of (-)-noradrenaline on trachea. The positive chronotropic effects of (+/-)-fenoterol on sinoatrial node were blocked more than those of both (-)-adrenaline and (-)-noradrenaline. A non-linear regression analysis of blocking data with ICI 118,551 according to the model of Lemoine and Kaumann (1983) revelas that both beta 1- and beta 2-adrenoceptors contribute to the tracheo-relaxant and positive chronotropic effects of agonists. The estimated equilibrium dissociation constants pKB (-log KB = pKB; mol/l) were 7.1 and 9.6 for beta 1- and beta 2-adrenoceptors, respectively. Tracheal beta 2-adrenoceptors contribute 99%, 97% and 7%, sinoatrial beta 2-adrenoceptors contribute 76%, 3% and 0% to the fractional stimuli induced by (+/-)-fenoterol, (-)-adrenaline and (-)-noradrenaline, respectively. 2. 3H-ICI associated to beta 2-adrenoceptors of lung membranes with a kon of 0.521 X nmol-1 X min-1 and dissociated with a koff of 0.19 min-1. 3H-ICI bound to lung beta 2-adrenoceptors with an equilibrium dissociation constant pKL* of 9.2. Unlabelled ICI 118,551, (-)-bupranolol, (+)-bupranolol, (-)-adrenaline, (-)-noradrenaline and (+/-)-fenoterol competed with 3H-ICI for lung beta 2-adrenoceptors with pKL-values of 9.0, 9.4, 8.1, 5.9, 4.9 and 6.4, respectively. 3. 3H-(-)-bupranolol associated to beta-adrenoceptors of lung membranes with a kon 1.21 X nmol-1 X min-1 and dissociated with a koff of 0.26 min-1. 3H-(-)-bupranolol bound to lung beta 2-adrenoceptors and to heart beta 1-adrenoceptors with a pKL of 9.6 and a pKL of 8.8, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
引入了一种能选择性标记β2 - 肾上腺素能受体的放射性配体3H - ICI 118,551(3H - ICI)。实验在豚鼠组织上进行。将3H - ICI在肺膜颗粒上的结合特性与ICI 118,551对( - ) - 去甲肾上腺素、( - ) - 肾上腺素和(±) - 非诺特罗气管舒张作用的阻断特性进行了比较。还用3H - ( - ) - 布普萘洛尔对肺和心室心肌进行了与β1 - 和β2 - 肾上腺素能受体的结合实验。将未标记的ICI 118,551在心室上的结合抑制特性与其作为( - ) - 去甲肾上腺素、( - ) - 肾上腺素和(±) - 非诺特罗在自发搏动右心房中正性变时作用拮抗剂的特性进行了比较。1. ICI 118,551对气管上(±) - 非诺特罗和( - ) - 肾上腺素舒张作用的阻断作用比对( - ) - 去甲肾上腺素的阻断作用更强。(±) - 非诺特罗对窦房结的正性变时作用比对( - ) - 肾上腺素和( - ) - 去甲肾上腺素的阻断作用更强。根据Lemoine和Kaumann(1983年)的模型对ICI 118,551的阻断数据进行非线性回归分析表明,β1 - 和β2 - 肾上腺素能受体均参与激动剂的气管舒张和正性变时作用。β1 - 和β2 - 肾上腺素能受体的估计平衡解离常数pKB( - log KB = pKB;mol/l)分别为7.1和9.6。气管β2 - 肾上腺素能受体对(±) - 非诺特罗、( - ) - 肾上腺素和( - ) - 去甲肾上腺素诱导的部分刺激的贡献率分别为99%、97%和7%,窦房结β2 - 肾上腺素能受体的贡献率分别为76%、3%和0%。2. 3H - ICI与肺膜β2 - 肾上腺素能受体结合的结合速率常数kon为0.521×nmol - 1×min - 1,解离速率常数koff为0.19 min - 1。3H - ICI与肺β2 - 肾上腺素能受体结合的平衡解离常数pKL*为9.2。未标记的ICI 118,551、( - ) - 布普萘洛尔、( + ) - 布普萘洛尔、( - ) - 肾上腺素、( - ) - 去甲肾上腺素和(±) - 非诺特罗与3H - ICI竞争肺β2 - 肾上腺素能受体,其pKL值分别为9.0、9.4、8.1、5.9、4.9和6.4。3. 3H - ( - ) - 布普萘洛尔与肺膜β - 肾上腺素能受体结合的结合速率常数kon为1.21×nmol - 1×min - 1,解离速率常数koff为0.26 min - 1。3H - ( - ) - 布普萘洛尔与肺β2 - 肾上腺素能受体和心脏β1 - 肾上腺素能受体结合的pKL分别为9.6和8.8。(摘要截选至400字)